Boji Medical Technology Co.,Ltd.

Equities

300404

CNE100001Y00

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
7.31 ^CNY	+0.55%		+9.76%	-18.32%

Apr. 25	Boji Medical Technology Co., Ltd. Announces Profit Distribution Proposal for 2023	CI
Apr. 24	Boji Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Boji Medical Technology Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 02 June 2022

May 26, 2022 at 03:58 pm EDT

Boji Medical Technology Co., Ltd. announced the 2021 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included) of CNY 0.20000000. Record date is 01 June 2022. Ex-date is 02 June 2022.
Payment date is 02 June 2022.

Latest news about Boji Medical Technology Co.,Ltd.

Boji Medical Technology Co., Ltd. Announces Profit Distribution Proposal for 2023	Apr. 24	CI
Boji Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Boji Medical Technology Inks 70 Million Yuan Technical Services Deal With Ruianbo Pharmaceutical Technology	Apr. 08	MT
Boji Medical Technology's Unit Gets Nod to Market Erectile Dysfunction Tablets	Mar. 12	MT
Tranche Update on Boji Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.	Mar. 04	CI
Boji Medical Technology Co.,Ltd.'s Equity Buyback announced on February 6, 2024, has closed with 2,667,000 shares, representing 0.72% for CNY 15.10 million.	Feb. 29	CI
Boji Medical Technology Bags 107.7 Million Yuan Clinical Trial Assistance Deal; Shares Surge 20%	Feb. 19	MT
Boji Medical Technology Co., Ltd. announces an Equity Buyback for CNY 20 million worth of its shares.	Feb. 05	CI
Boji Medical Technology Co., Ltd. authorizes a Buyback Plan.	Feb. 04	CI
Boji Medical Scores 54 Million Yuan Contract For Eye Drop Clinical Trial Research	Jan. 26	MT
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Boji Medical Technology Co., Ltd. Approves the Election of Directors and Non-Employee Supervisors	23-08-03	CI
Boji Medical Technology Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 11 July 2023	23-07-04	CI
Boji Medical Technology Co., Ltd. Proposes Cash Dividend for 2022	23-04-26	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Boji Medical Technology Gets Warning for Disclosure Breaches; Shares Jump 7%	23-02-28	MT
Boji Medical’s Chairman to Boost Stake to 39% After 84 Million Yuan Deal; Shares Rally 14%	23-02-15	MT
Boji Medical Technology Co., Ltd. announced that it expects to receive CNY 83.999999 million in funding	23-02-13	CI
Boji Medical Signs 55.5 Million Yuan Deal to Complete Trial of Therapeutic Drug	22-12-28	MT
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Boji Medical Technology Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 02 June 2022	22-05-26	CI
Boji CRO Approves Cash Dividend for the Year 2021	22-05-18	CI
Boji Medical Technology Co., Ltd. Proposes Final Cash Dividend for 2021	22-04-26	CI

Chart Boji Medical Technology Co.,Ltd.

Duration

Period

More charts

Company Profile

Boji Medical Technology Co Ltd is a China-based company that provides Contract Research Organization (CRO) services. The Company mainly provides one-stop CRO services for the development and production of new drugs and medical devices for domestic and foreign pharmaceutical companies and other research institutions. The Company's CRO services include pre-clinical research services, clinical research services, other consulting services, pharmaceutical Contract Development Manufacture Organization (CDMO) services, pre-clinical independent research and development services, and technology achievement transformation services. The Company mainly conducts its businesses in the domestic market.

Sector

Biotechnology & Medical Research

Calendar

2024-05-16 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
BOJI MEDICAL TECHNOLOGY CO.,LTD.	-18.32%	385M
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research